KANAMYCIN (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the KANAMYCIN drug offered from Fresenius Kabi USA, LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
| NON-PROPRIETARY NAME: | KANAMYCIN |
| SUBSTANCE NAME: | KANAMYCIN A SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2003-01-28 |
| END MARKETING DATE: | 0000-00-00 |
KANAMYCIN HUMAN PRESCRIPTION DRUG Details:
| Item Description | KANAMYCIN from Fresenius Kabi USA, LLC |
| LABELER NAME: | Fresenius Kabi USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 333(mg/mL) |
| START MARKETING DATE: | 2003-01-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-359_d50696cd-0f4c-4ba0-a0bf-3af5159ab17e |
| PRODUCT NDC: | 63323-359 |
| APPLICATION NUMBER: | ANDA065111 |
Other KANAMYCIN A SULFATE Pharmaceutical Manufacturers / Labelers:
